{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:17:22Z","timestamp":1769559442551,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is a growing concern that the use of anti-hypertensives may be associated with an increased risk of cancer, but it remains uncertain for the association between anti-hypertensives and lung cancer risk, as well as their interaction with aspirin in chemoprotective effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The goal of this study is to assess the association between anti-hypertensives use and the risk of lung cancer, as well as the chemopreventive impacts from the combination usage of aspirin and anti-hypertensives. A retrospective cohort study was conducted based on all the public hospital electronic medical records in Hong Kong. Patients with prescription records of anti-hypertensives (ACEi\/ARB, CCB, <jats:italic>\u03b2<\/jats:italic>-blocker,<jats:italic>\u03b1<\/jats:italic>-blocker) and\/or aspirin were included as the exposure groups. Using the Cox proportional hazards model with inverse probability weighting, we estimated hazard ratios (HRs) with 95% confidence intervals (CIs) for lung cancer risk from anti-hypertensives usage or combination usage of aspirin with anti-hypertensives. The likelihood ratio test and interaction model were adopted for exploring the interaction effects with aspirin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 6592 and 84,116 lung cancer cases were identified from the groups of anti-hypertensives users and anti-hypertensives users with aspirin, respectively. The group of non-aspirin patients who received anti-hypertensives showed a significantly lower risk of lung cancer (HR: 0.63, 95% CI: 0.60\u20130.66), compared to those without anti-hypertensives<jats:bold>.<\/jats:bold> When aspirin and <jats:italic>\u03b1<\/jats:italic>-blocker were used simultaneously, it could lower the risk of lung cancer significantly (HR: 0.53, 95% CI: 0.34\u20130.84). Moreover, the lower risk of lung cancer persisted with a longer follow-up period of anti-hypertensives usage. Combination usage with aspirin in the users of ACEi\/ARB, CCB, and <jats:italic>\u03b1<\/jats:italic>-blocker showed significant interaction effects. However, the smoking effect could not be eliminated in this analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Anti-hypertensive treatment was associated with a lower risk of lung cancer, which is associated with the anti-hypertensives exposure period. The potential interaction on the chemopreventive influence from combination usage of \u03b1-blocker and aspirin might exist. More corroborations on these findings are needed to focus on the different settings in future studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08971-6","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:03:39Z","timestamp":1636632219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antihypertensive treatments and risks of lung Cancer: a large population-based cohort study in Hong Kong"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinhui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S. M.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah T. Y.","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K. L.","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin K. F.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"8971_CR1","unstructured":"World Health Organization: Cancer. 2018 [Internet]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"issue":"1","key":"8971_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12885-015-1615-0","volume":"15","author":"CJ Ng","year":"2015","unstructured":"Ng CJ, Teo CH, Abdullah N, Tan WP, Tan HM. Relationships between cancer pattern, country income and geographical region in Asia. BMC Cancer. 2015;15(1):613. https:\/\/doi.org\/10.1186\/s12885-015-1615-0.","journal-title":"BMC Cancer"},{"key":"8971_CR3","unstructured":"Department of Health, The Government of the Hong Kong Special Administrative Region: Center for Health Protection. Lung Cancer. 2020[Internet]. Available from: https:\/\/www.chp.gov.hk\/en\/healthtopics\/content\/25\/49.html."},{"issue":"5","key":"8971_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.rcl.2012.06.006","volume":"50","author":"P de Groot","year":"2021","unstructured":"de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin N Am. 2021;50(5):863\u201376. https:\/\/doi.org\/10.1016\/j.rcl.2012.06.006.","journal-title":"Radiol Clin N Am"},{"issue":"5 Suppl","key":"8971_CR5","doi-asserted-by":"publisher","first-page":"e1S","DOI":"10.1378\/chest.12-2345","volume":"143","author":"AJ Alberg","year":"2013","unstructured":"Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e1S\u2013e29S. https:\/\/doi.org\/10.1378\/chest.12-2345.","journal-title":"Chest."},{"issue":"1","key":"8971_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ijc.32083","volume":"145","author":"KKF Tsoi","year":"2019","unstructured":"Tsoi KKF, Ho JMW, Chan FCH, Sung JJY. Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong. Int J Cancer. 2019;145(1):267\u201373. https:\/\/doi.org\/10.1002\/ijc.32083.","journal-title":"Int J Cancer"},{"issue":"3","key":"8971_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0185","volume":"2","author":"S Ye","year":"2019","unstructured":"Ye S, Lee M, Lee D, Ha EH, Chun EM. Association of Long-term use of low-dose aspirin as chemoprevention with risk of lung Cancer. JAMA Netw Open. 2019;2(3):e190185. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.0185.","journal-title":"JAMA Netw Open"},{"key":"8971_CR8","doi-asserted-by":"publisher","first-page":"k4209","DOI":"10.1136\/bmj.k4209","volume":"363","author":"BM Hicks","year":"2018","unstructured":"Hicks BM, Filion KB, Yin H, Sakr L, Udell JA, Azoulay L. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. BMJ. 2018;363:k4209. https:\/\/doi.org\/10.1136\/bmj.k4209.","journal-title":"BMJ."},{"issue":"11","key":"8971_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/pds.1656","volume":"17","author":"TL Assimes","year":"2008","unstructured":"Assimes TL, Elstein E, Langleben A, Suissa S. Long-term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiol Drug Saf. 2008;17(11):1039\u201349. https:\/\/doi.org\/10.1002\/pds.1656.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"8971_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00129784-200202020-00002","volume":"2","author":"CV Ram","year":"2012","unstructured":"Ram CV. Antihypertensive drugs: an overview. Am J Cardiovasc Drugs. 2012;2(2):77\u201389. https:\/\/doi.org\/10.2165\/00129784-200202020-00002.","journal-title":"Am J Cardiovasc Drugs"},{"key":"8971_CR11","unstructured":"Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region: Report of Population Health Survey 2014\/2015. 2017[Internet]. Available from: https:\/\/www.chp.gov.hk\/files\/pdf\/dh_phs_2014_15_full_report_eng.pdf."},{"issue":"10","key":"8971_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/jhh.2008.83","volume":"22","author":"MC Wong","year":"2008","unstructured":"Wong MC, Jiang JY, Lam AT, Fung H, Griffiths S, Mercer SW. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens. 2008;22(10):714\u20136. https:\/\/doi.org\/10.1038\/jhh.2008.83.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"8971_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","volume":"12","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials. Lancet Oncol. 2011;12(1):65\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(10)70260-6.","journal-title":"Lancet Oncol"},{"issue":"apr24 1","key":"8971_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e2697","volume":"344","author":"K Bhaskaran","year":"2012","unstructured":"Bhaskaran K, Douglas I, Evans S, van Staa T, Smeeth L. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK general practice research database. BMJ. 2012;344(apr24 1):e2697. https:\/\/doi.org\/10.1136\/bmj.e2697.","journal-title":"BMJ."},{"issue":"3","key":"8971_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/cancers12030747","volume":"12","author":"SY Lin","year":"2020","unstructured":"Lin SY, Lin CL, Lin CC, Hsu WH, Lin CD, Wang IK, et al. Association between angiotensin-converting enzyme inhibitors and lung Cancer-a Nationwide, population-based, propensity score-matched cohort study. Cancers (Basel). 2020;12(3):747. https:\/\/doi.org\/10.3390\/cancers12030747.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"8971_CR16","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/aje\/kwz106","volume":"188","author":"Y Cui","year":"2019","unstructured":"Cui Y, Wen W, Zheng T, Li H, Gao Y, Cai H, et al. Use of antihypertensive medications and survival rates for breast, colorectal, lung, or stomach Cancer. Am J Epidemiol. 2019;188(8):1512\u201328. https:\/\/doi.org\/10.1093\/aje\/kwz106.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"8971_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1060028018814684","volume":"53","author":"V Rotshild","year":"2019","unstructured":"Rotshild V, Azoulay L, Feldhamer I, Perlman A, Glazer M, Muszkat M, et al. Calcium Channel blockers and the risk for lung Cancer: a population-based nested case-control study. Ann Pharmacother. 2019;53(5):445\u201352. https:\/\/doi.org\/10.1177\/1060028018814684.","journal-title":"Ann Pharmacother"},{"key":"8971_CR18","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration: Aspirin in the primary and secondary prevention of vascular disease- collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009:373;1849\u201360.","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"8971_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.phrs.2019.01.037","volume":"141","author":"M Tadic","year":"2019","unstructured":"Tadic M, Cuspidi C, Belyavskiy E, Grassi G. Intriguing relationship between antihypertensive therapy and cancer. Pharmacol Res. 2019;141:501\u201311. https:\/\/doi.org\/10.1016\/j.phrs.2019.01.037.","journal-title":"Pharmacol Res"},{"issue":"14","key":"8971_CR20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1096\/fj.03-0129com","volume":"17","author":"T Walther","year":"2003","unstructured":"Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M. Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J. 2003;17(14):2061\u20137. https:\/\/doi.org\/10.1096\/fj.03-0129com.","journal-title":"FASEB J"},{"issue":"10","key":"8971_CR21","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2093::AID-CNCR1>3.0.CO;2-E","volume":"85","author":"RP Mason","year":"1999","unstructured":"Mason RP. Effects of calcium channel blockers on cellular apoptosis. Cancer. 1999;85(10):2093\u2013102. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19990515)85:10<2093::AID-CNCR1>3.0.CO;2-E.","journal-title":"Cancer."},{"issue":"2","key":"8971_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mrrev.2005.12.002","volume":"612","author":"G Brambilla","year":"2006","unstructured":"Brambilla G, Martelli A. Genotoxicity and carcinogenicity studies of antihypertensive agents. Mutat Res. 2006;612(2):115\u201349. https:\/\/doi.org\/10.1016\/j.mrrev.2005.12.002.","journal-title":"Mutat Res"},{"issue":"4467","key":"8971_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.7423193","volume":"210","author":"GM Williams","year":"1980","unstructured":"Williams GM, Mazue G, McQueen CA, Shimada T. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine. Science. 1980;210(4467):329\u201330. https:\/\/doi.org\/10.1126\/science.7423193.","journal-title":"Science."},{"issue":"7","key":"8971_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","volume":"16","author":"FN Deshayes","year":"2005","unstructured":"Deshayes FN. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab. 2005;16(7):293\u20139. https:\/\/doi.org\/10.1016\/j.tem.2005.07.009.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"8971_CR25","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-09-0161","volume":"8","author":"DR Soto-Pantoja","year":"2009","unstructured":"Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. A Mol Cancer Ther. 2009;8(6):1676\u201383. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0161.","journal-title":"A Mol Cancer Ther"},{"key":"8971_CR26","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2147\/CMAR.S228718","volume":"12","author":"B Wong","year":"2020","unstructured":"Wong B, Chiu L, Tu D, Sheu G, Chan T. Anticancer effects of antihypertensive L-type Calcium Channel blockers on Chemoresistant lung Cancer cells via autophagy and apoptosis. Cancer Manag Res. 2020;12:1913\u201327. https:\/\/doi.org\/10.2147\/CMAR.S228718.","journal-title":"Cancer Manag Res"},{"issue":"8","key":"8971_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/MPA.0000000000000886","volume":"46","author":"JJ Dai","year":"2017","unstructured":"Dai JJ, Jiang MJ, Wang XP, Tian L. Inflammation-related pancreatic carcinogenesis: mechanisms and clinical potentials in advances. Pancreas. 2017;46(8):973\u201385. https:\/\/doi.org\/10.1097\/MPA.0000000000000886.","journal-title":"Pancreas."},{"issue":"35","key":"8971_CR28","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.2174\/1381612821666150915110706","volume":"21","author":"L Di Francesco","year":"2015","unstructured":"Di Francesco L, L\u00f3pez Contreras LA, Sacco A, Patrignani P. New insights into the mechanism of action of aspirin in the prevention of colorectal neoplasia. Curr Pharm Des. 2015;21(35):5116\u201326. https:\/\/doi.org\/10.2174\/1381612821666150915110706.","journal-title":"Curr Pharm Des"},{"issue":"suppl 1","key":"8971_CR29","doi-asserted-by":"publisher","first-page":"s78","DOI":"10.2337\/diacare.25.2007.S78","volume":"25","author":"American Diabetes Association","year":"2002","unstructured":"American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care. 2002;25(suppl 1):s78\u2013S79. https:\/\/doi.org\/10.2337\/diacare.25.2007.S78.","journal-title":"Diabetes Care"},{"issue":"5","key":"8971_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/HCO.0000000000000204","volume":"30","author":"JJ Prochaska","year":"2015","unstructured":"Prochaska JJ, Benowitz NL. Smoking cessation and the cardiovascular patient. Curr Opin Cardiol. 2015;30(5):506\u201311. https:\/\/doi.org\/10.1097\/HCO.0000000000000204.","journal-title":"Curr Opin Cardiol"},{"issue":"7","key":"8971_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jama.2019.11166","volume":"322","author":"TB Cole","year":"2019","unstructured":"Cole TB. Smoking cessation and reduction of cardiovascular disease risk. JAMA. 2019;322(7):651. https:\/\/doi.org\/10.1001\/jama.2019.11166.","journal-title":"JAMA."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08971-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08971-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08971-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:06:14Z","timestamp":1636632374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08971-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8971"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08971-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the standard guidelines of Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). Due to that all the patients were reached anonymously and allocated by a special identifier according to the policy of Hong Kong Hospital Authority from Hong Kong government, the consent to participate was not applicable and the informed consent was waived, by the ethical approval reached from the Joint Chinese University of Hong Kong - New Territories East Cluster Clinical Research Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1202"}}